NCT07790952

Brief Summary

To determine the frequency of mesh infection in patient with open Incisional hernioplasty and to compare factors contributing with and without mesh infection

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2026

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2026

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

August 22, 2026

Last Update Submit

August 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number and percentage of participants with Mesh related infection following open Incisional hernioplasty

    Development of mesh related infection following open Incisional hernioplasty assessed during postoperative followup will be accessed by clinical examination of the surgical site. The outcome will be measured as the number of participants who developed mesh related infection and percentage of mesh related infection.

    1 month, 3 months and 1 year after surgery

Study Arms (1)

Mesh infection

Participants undergoing open Incisional hernioplasty who develop mesh related infection during the postoperative followup period

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient of all age group and both genders with Incisional hernia undergoing open mesh hernioplasty will be consecutively enrolled and followed postoperative to access the development of mesh infection and associated predictors

You may qualify if:

  • All age group patient will be included
  • Both genders will be involved in this study
  • Incisional hernia as per operational definition

You may not qualify if:

  • Co- Morbid condition including hypertension, Tuberculosis and Autoimmune disease
  • Parents refusing for consent
  • Immunocompromised patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Faisal Masood teaching Hospital Sargodha

Sargodha, Punjab Province, 40100, Pakistan

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2026

First Posted

August 27, 2026

Study Start

September 22, 2025

Primary Completion

July 25, 2026

Study Completion

July 29, 2026

Last Updated

August 27, 2026

Record last verified: 2026-08

Locations